Cet anticorps anti-CDC42BPB Polyclonal Lapin (ABIN498363) détecte spécifiquement CDC42BPB dans WB et IHC (p).
L’anticorps est réactif avec des échantillons de Humain, Rat et Souris.
CDC42BPB
Reactivité: Humain, Rat, Souris
ELISA, WB, IHC
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Western Blot: 1/500 - 1/1000. Immunohistochemistry: 1/50 - 1/200. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
4 °C/-20 °C
Stockage commentaire
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Antigène
CDC42BPB
(CDC42 Binding Protein Kinase beta (DMPK-Like) (CDC42BPB))
Autre désignation
CDC42BPB
Sujet
Protein kinases comprise a large group of encoded factors that regulate cellular processes by catalyzing the transfer of a phosphate group to a hydroxyl acceptor in serine, threonine or tyrosine residues. Myotonic dystrophy kinaserelated Cdc42-binding (DMPK-like) kinases-alpha and beta (MRCK-alpha, beta) contain a cysteine-rich motif and a putative pleckstrin homology domain. MRCKs can phosphorylate nonmuscle Myosin light chain and influences Actin-Myosin contractility. MRCK-alpha can phosphorylate and activate LIM kinases downstream of Cdc42, which leads to inactivation of ADF/Cofilin and to Actin cytoskeletal reorganization. MRCK-alpha can also influence neurite outgrowth promoted by Cdc42 and Rac.Synonyms: CDC42-binding protein kinase beta, DMPK-like beta, KIAA1124, MRCK beta, Myotonic dystrophy kinase-related CDC42-binding kinase beta, Serine/threonine-protein kinase MRCK beta